The difficulty of making a malignant mesothelioma diagnosis continues to stimulate discussion in the medical community. Last month, Dr. Aliya Husain from the Department of Pathology at the University of Chicago, and her colleague Qudsia Arif, published a short and direct article titled “Malignant Mesothelioma Diagnosis” in Archives of Pathology and Laboratory Medicine. The published context for the article states “mesothelioma is a relatively rare pleural tumor that may mimic benign mesothelial lesions and various other tumors . . . this makes the diagnosis challenging for the pathologist.” This blog has discussed some of those difficulties in prior posts here and here.
Continue Reading Diagnosing Mesothelioma Continues to Challenge Pathologists

A definitive diagnosis of malignant pleural mesothelioma based on cytology alone is fraught with problems, and should be thoroughly investigated by attorneys on both sides of the litigation according to a Law 360 article authored by Schiff Hardin partners Edward Casmere and Joshua D. Lee.  Asbestos litigants are increasingly presented with fewer medical records